Alyeska Investment Group’s BioNTech BNTX Stock Holding History

Alyeska Investment Group’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Sell	28,279 -48,671	-63%	-$4.58M	0.01%	553
2026 Q1	$6.84M	Buy	+76,950	New	+$7.91M	0.02%	439
2025 Q4	–	Sell	-57,668	Closed	-$5.69M	–	595
2025 Q3	$5.69M	Buy	+57,668	New	+$6.17M	0.02%	442
2025 Q2	–	Sell	-75,000	Closed	-$6.83M	–	571
2025 Q1	$6.83M	Buy	75,000 +72,386	+2,769%	+$8.1M	0.03%	344
2024 Q4	$298K	Buy	+2,614	New	+$298K	﹤0.01%	531

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Alyeska Investment Group's BNTX Position: Q2 2026 in Review

Alyeska Investment Group reduced its BioNTech (BNTX) stake by 63% in Q2 2026, selling an estimated $4.58M and leaving 28,279 shares worth $2.63M. The position accounts for 0.01% of the portfolio, ranked #553.

Alyeska Investment Group first reported a position in BNTX in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.84M in Q1 2026. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Alyeska Investment Group held 28,279 shares of BioNTech worth $2.63M as of Q2 2026.
Alyeska Investment Group sold 48,671 BioNTech shares in Q2 2026, an estimated $4.58M.
BioNTech made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #553 holding.
Alyeska Investment Group first reported a position in BioNTech in Q4 2024 and has held it in 5 quarters since.
Alyeska Investment Group's BioNTech position peaked at $6.84M in Q1 2026.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.